Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique

BACKGROUND Occult hepatitis B virus (HBV) - characterized by the absence of detectable HBsAg in the presence of HBV DNA - represents a potential threat for blood safety. OBJECTIVES This study was conducted with the aim to investigate the serological and molecular characterization of occult HBV infection (OBI) among blood donors in Mozambique. METHODS 1,502 blood donors were tested for HBsAg. All HBsAg-negative individuals were tested for HBV DNA. Antibodies against HBV core, surface and HBe antigen (anti-HBc, anti-HBs, HBeAg) were measured in HBV DNA positive individuals. FINDINGS 1435 serum samples were HBsAg negative and 16 positive for HBV DNA, 14 confirmed to have OBI, corresponding to a frequency of 0.98%. Of the 14 OBI infections identified, 13/14 (92.8%) were positive for anti-HBc, 4/14 (28.5%) for anti-HBs, and no samples were reactive for HBeAg. Of the 14 OBI cases, nine samples (64.2%) were sequenced for the S/P region. Eight samples (88.9%) belonged to genotype A1 and one (11.1%) to genotype E. One escape mutation (T123A) associated with OBI and various amino acid substitutions for genotype A1 and E were observed. MAIN CONCLUSIONS Our results show the importance of using nucleic acid amplification test to detect occult hepatitis B infection in blood donors in Mozambique.

Saved in:
Bibliographic Details
Main Authors: Mabunda,Nédio, Zicai,Ana Flora, Ismael,Nalia, Vubil,Adolfo, Mello,Francisco, Blackard,Jason T, Lago,Barbara, Duarte,Vanessa, Moraes,Milton, Lewis,Lia, Jani,Ilesh
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100339
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762020000100339
record_format ojs
spelling oai:scielo:S0074-027620200001003392020-09-18Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, MozambiqueMabunda,NédioZicai,Ana FloraIsmael,NaliaVubil,AdolfoMello,FranciscoBlackard,Jason TLago,BarbaraDuarte,VanessaMoraes,MiltonLewis,LiaJani,Ilesh occult hepatitis B blood donors Mozambique BACKGROUND Occult hepatitis B virus (HBV) - characterized by the absence of detectable HBsAg in the presence of HBV DNA - represents a potential threat for blood safety. OBJECTIVES This study was conducted with the aim to investigate the serological and molecular characterization of occult HBV infection (OBI) among blood donors in Mozambique. METHODS 1,502 blood donors were tested for HBsAg. All HBsAg-negative individuals were tested for HBV DNA. Antibodies against HBV core, surface and HBe antigen (anti-HBc, anti-HBs, HBeAg) were measured in HBV DNA positive individuals. FINDINGS 1435 serum samples were HBsAg negative and 16 positive for HBV DNA, 14 confirmed to have OBI, corresponding to a frequency of 0.98%. Of the 14 OBI infections identified, 13/14 (92.8%) were positive for anti-HBc, 4/14 (28.5%) for anti-HBs, and no samples were reactive for HBeAg. Of the 14 OBI cases, nine samples (64.2%) were sequenced for the S/P region. Eight samples (88.9%) belonged to genotype A1 and one (11.1%) to genotype E. One escape mutation (T123A) associated with OBI and various amino acid substitutions for genotype A1 and E were observed. MAIN CONCLUSIONS Our results show the importance of using nucleic acid amplification test to detect occult hepatitis B infection in blood donors in Mozambique.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.115 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100339en10.1590/0074-02760200006
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Mabunda,Nédio
Zicai,Ana Flora
Ismael,Nalia
Vubil,Adolfo
Mello,Francisco
Blackard,Jason T
Lago,Barbara
Duarte,Vanessa
Moraes,Milton
Lewis,Lia
Jani,Ilesh
spellingShingle Mabunda,Nédio
Zicai,Ana Flora
Ismael,Nalia
Vubil,Adolfo
Mello,Francisco
Blackard,Jason T
Lago,Barbara
Duarte,Vanessa
Moraes,Milton
Lewis,Lia
Jani,Ilesh
Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
author_facet Mabunda,Nédio
Zicai,Ana Flora
Ismael,Nalia
Vubil,Adolfo
Mello,Francisco
Blackard,Jason T
Lago,Barbara
Duarte,Vanessa
Moraes,Milton
Lewis,Lia
Jani,Ilesh
author_sort Mabunda,Nédio
title Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
title_short Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
title_full Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
title_fullStr Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
title_full_unstemmed Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique
title_sort molecular and serological characterization of occult hepatitis b among blood donors in maputo, mozambique
description BACKGROUND Occult hepatitis B virus (HBV) - characterized by the absence of detectable HBsAg in the presence of HBV DNA - represents a potential threat for blood safety. OBJECTIVES This study was conducted with the aim to investigate the serological and molecular characterization of occult HBV infection (OBI) among blood donors in Mozambique. METHODS 1,502 blood donors were tested for HBsAg. All HBsAg-negative individuals were tested for HBV DNA. Antibodies against HBV core, surface and HBe antigen (anti-HBc, anti-HBs, HBeAg) were measured in HBV DNA positive individuals. FINDINGS 1435 serum samples were HBsAg negative and 16 positive for HBV DNA, 14 confirmed to have OBI, corresponding to a frequency of 0.98%. Of the 14 OBI infections identified, 13/14 (92.8%) were positive for anti-HBc, 4/14 (28.5%) for anti-HBs, and no samples were reactive for HBeAg. Of the 14 OBI cases, nine samples (64.2%) were sequenced for the S/P region. Eight samples (88.9%) belonged to genotype A1 and one (11.1%) to genotype E. One escape mutation (T123A) associated with OBI and various amino acid substitutions for genotype A1 and E were observed. MAIN CONCLUSIONS Our results show the importance of using nucleic acid amplification test to detect occult hepatitis B infection in blood donors in Mozambique.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762020000100339
work_keys_str_mv AT mabundanedio molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT zicaianaflora molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT ismaelnalia molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT vubiladolfo molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT mellofrancisco molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT blackardjasont molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT lagobarbara molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT duartevanessa molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT moraesmilton molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT lewislia molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
AT janiilesh molecularandserologicalcharacterizationofocculthepatitisbamongblooddonorsinmaputomozambique
_version_ 1756383914701619200